TAIPEI, Taiwan--(BUSINESS WIRE)-- iStaging is an innovative Mixed Reality SaaS company driven by computer vision & AI, backed by 10 years of technological development and 100,000 corporate users around the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240522635432/en/
iStaging reveals Next Generation MR experiences at VivaTech 2024 (Photo: Business Wire)
iStaging joined VivaTech this year to... (continue reading...)
Will initially produce low-voltage circuit breakers for factory-automation products in ASEAN region
TOKYO--(BUSINESS WIRE)-- Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will acquire an 80% stake in Fuji Bakelite Vietnam Co., Ltd. in outskirts of Hanoi, a subsidiary of Fuji Bakelite Co., Ltd. in Okayama Prefecture, Japan. The new joint venture (JV) company, to be named Mitsubishi Electric FP Automation Vietnam Co., Ltd., will be... (continue reading...)
ZHEJIANG, Zhoushan--(BUSINESS WIRE)-- On May 17, in Zhoushan, Zhejiang Province, the world's first five-terminal flexible DC transmission project, Zhoushan five-terminal VSC-HVDC transmission project, is undergoing a complete overhaul for the first time after it was put into operation. Aeroamphibious intelligent equipment and advanced technology are used in this overhaul, in order to greatly enhance working efficiency by decreasing the overhaul duration in the... (continue reading...)
- Omlyclo® (CT-P39), used to treat allergic asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic spontaneous urticaria (CSU), becomes the first omalizumab biosimilar approved in the European Union
- The European Commission (EC) decision is based on clinical evidence, including results from a Phase III clinical trial demonstrating a comparable efficacy and safety profile with the reference product Xolair®
- Omlyclo® is the first omalizumab... (continue reading...)
NEW ORLEANS--(BUSINESS WIRE)--
The 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessions Milestone Moment, Janet Jackson, Charlie Wilson, Victoria Monét, Birdman & Friends Presents 30 Years of Cash Money Millionaires, A Special Passing of the Torch by Frankie Beverly & Maze and more!
Legacy will take center stage as the 2024 ESSENCE Festival of... (continue reading...)
More Business Wire
View Older Stories-
Lee Leads Wire-to-Wire to Win MLF General Tire Heavy Hitters 2024 Presented by Bass Pro Shops on the Kissimmee Chain of Lakes
-
Alibaba Group Prices US$4,500 Million Offering of Convertible Senior Notes
-
Sensedia Launches AI Copilot to Accelerate and Enhance API Development
-
FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
-
Limbach Holdings to Participate in Stifel Conference
-
FCPT Announces Sale Leaseback of Eight Mavis Tire Operated Properties for $20 Million
-
Aqua Pennsylvania Files Rate Request Based on Water and Wastewater Operations, Infrastructure Improvements and Repairs Across the Commonwealth
-
Browning West Announces Successful Replacement of Gildan Activewear’s Entire Board of Directors with Full Eight-Member Slate
-
Golden Entertainment Announces Repricing of Term Loan
-
Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala Honors the Los Angeles Chargers and Students Run LA on the 50-yard Line of SoFi Stadium on June 8, 2024
-
Power Integrations to Present at Upcoming Investor Conferences
-
SSR Mining Announces Voting Results From 2024 Annual and Special Meeting of Shareholders
-
Pan American Silver Releases 2023 Sustainability Report
-
Crypto Specialist Bitwise’s First-Ever Spot Ethereum ETF Receives Key SEC Approval
-
Pei enters the MSCI COLCAP index
-
Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers
-
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
-
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
-
NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
-
Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
-
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
-
Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel
-
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
-
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
-
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
-
TelevisaUnivision Announces Pricing of $1.0 Billion Debt
-
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares Distribution
-
KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
-
Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase Program
-
Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First
-
NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
-
Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
-
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
-
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
-
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
-
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
-
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth Strategy
-
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
-
NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Socie
-
AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer
-
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
-
Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual Meeting
-
Klaviyo to Present at the William Blair Growth Stock Conference
-
Dentalcorp Announces Annual General Meeting Voting Results
-
Ligand to Participate in Upcoming Investor Conferences
-
Genworth Financial Announces Results of Annual Meeting